Non-alcoholic fatty liver disease is characterised by a reduced polyunsaturated fatty acid transport via free fatty acids and high-density lipoproteins (HDL)

被引:21
|
作者
Mocciaro, Gabriele [1 ,2 ]
Allison, Michael [3 ]
Jenkins, Benjamin [4 ]
Azzu, Vian [3 ,4 ]
Huang-Doran, Isabel [3 ]
Herrera-Marcos, Luis Vicente [5 ]
Hall, Zoe [6 ]
Murgia, Antonio [1 ,4 ]
Susan, Davies [3 ,4 ]
Frontini, Mattia [7 ]
Vidal-Puig, Antonio
Koulman, Albert [4 ]
Griff, Julian L. [1 ,8 ]
Vacca, Michele [1 ,2 ,4 ,9 ,10 ]
机构
[1] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England
[2] Fdn Liver Res, Roger Williams Inst Hepatol, London SE5 9NT, England
[3] Addenbrookes Hosp, Cambridge Biomed Res Ctr, Dept Med, Cambridge, England
[4] Wellcome Trust MRC Inst Metab Sci, Metab Res Labs, Cambridge CB2 0QQ, England
[5] Univ Zaragoza, Vet Fac, Dept Biochem & Mol & Cellular Biol, Zaragoza 50013, Spain
[6] Imperial Coll London, Dept Metab Digest & Reprod, Div Syst Med, Biomol Med, London SW7 2AZ, England
[7] Univ Exeter, Fac Hlth & Life Sci, Clin & Biomed Sci, Med Sch, RILD Bldg,Barrack Rd, Exeter EX2 5DW, England
[8] Univ Aberdeen, Rowett Inst, Foresterhill Campus, Aberdeen AB25 2ZD, Scotland
[9] Aldo Moro Univ Bari, Dept Interdisciplinary Med, Clin Med C Frugoni, I-70124 Bari, Italy
[10] Aldo Moro Univ Bari, Dept Interdisciplinary Med, Clin Med C Frugoni, I-70124 Bari, Italy
来源
MOLECULAR METABOLISM | 2023年 / 73卷
基金
英国医学研究理事会;
关键词
Non-alcoholic fatty liver disease (NAFLD); Obesity; Lipoprotein metabolism; Lipidomics; LC-MS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; CHOLESTEROL EFFLUX; HEPATIC STEATOSIS; SCORING SYSTEM; METABOLISM; MARKERS; PHOSPHATIDYLCHOLINE; TRIACYLGLYCEROL; SPHINGOMYELIN;
D O I
10.1016/j.molmet.2023.101728
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives: Non-alcoholic fatty liver disease (NAFLD) develops due to impaired hepatic lipid fluxes and is a risk factor for chronic liver disease and atherosclerosis. Lipidomic studies consistently reported characteristic hepatic/VLDL "lipid signatures" in NAFLD; whole plasma traits are more debated. Surprisingly, the HDL lipid composition by mass spectrometry has not been characterised across the NAFLD spectrum, despite HDL being a possible source of hepatic lipids delivered from peripheral tissues alongside free fatty acids (FFA). This study characterises the HDL lipidomic signature in NAFLD, and its correlation with metabolic and liver disease markers.Methods: We used liquid chromatography-mass spectrometry to determine the whole serum and HDL lipidomic profile in 89 biopsy-proven NAFLD patients and 20 sex and age-matched controls. Results: In the whole serum of NAFLD versus controls, we report a depletion in polyunsaturated (PUFA) phospholipids (PL) and FFA; with PUFA PL being also lower in HDL, and negatively correlated with BMI, insulin resistance, triglycerides, and hepatocyte ballooning. In the HDL of the NAFLD group we also describe higher saturated ceramides, which positively correlate with insulin resistance and transaminases.Conclusion: NAFLD features lower serum lipid species containing polyunsaturated fatty acids; the most affected lipid fractions are FFA and (HDL) phospholipids; our data suggest a possible defect in the transfer of PUFA from peripheral tissues to the liver in NAFLD. Mechanistic studies are required to explore the biological implications of our findings addressing if HDL composition can influence liver metabolism and damage, thus contributing to NAFLD pathophysiology.(c) 2023 Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease
    Mouzaki, Marialena
    Wang, Alice Y.
    Bandsma, Robert
    Comelli, Elena M.
    Arendt, Bianca M.
    Zhang, Ling
    Fung, Scott
    Fischer, Sandra E.
    McGilvray, Ian G.
    Allard, Johane P.
    PLOS ONE, 2016, 11 (05):
  • [42] REDUCED HEPATIC MITOCHONDRIAL FATTY ACID OXIDATION IN VETERANS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AND HEPATIC FIBROSIS
    Sharma, Neal
    HEPATOLOGY, 2021, 74 : 1121A - 1122A
  • [43] NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC FATTY PANCREAS DISEASE: A NEW INTRIGUING ASSOCIATION?
    Della Corte, Claudia
    Mosca, Antonella
    Sartorelli, Maria Rita
    Comparcola, Donatella
    Liccardo, Daniela
    Alterio, Arianna
    Lucidi, Vincenzina
    Nobili, Valerio
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : E101 - E101
  • [44] NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS RELATED TO NON-ALCOHOLIC FATTY PANCREAS DISEASE (NAFPD)
    van Geenen, Erwin-Jan M.
    Smits, Mark M.
    Schreuder, Tim C.
    Bloemena, Elisabeth
    van der Peet, Donald L.
    Mulder, Chris J.
    HEPATOLOGY, 2009, 50 (04) : 788A - 788A
  • [45] ASSOCIATION OF PLASMA PHOSPHOLIPID FATTY ACID CONCENTRATIONS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
    Wierzbicka, A.
    Socha, P.
    Plutecki, M.
    Janczyk, W.
    Neuhoff-Murawska, J.
    Dzik, E.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2010, 50 : E165 - E166
  • [46] Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease
    Leamy, Alexandra K.
    Egnatchik, Robert A.
    Young, Jamey D.
    PROGRESS IN LIPID RESEARCH, 2013, 52 (01) : 165 - 174
  • [47] The significance of omega-3 fatty acids in the treatment of non-alcoholic fatty liver disease
    Mako, Rebeka Anna
    Egresi, Anna
    Blazovics, Anna
    Oszlanyi, Reka
    Hagymasi, Krisztina
    ORVOSI HETILAP, 2023, 164 (33) : 1294 - 1299
  • [48] Free Fatty Acids Differentially Downregulate Chemokines in Liver Sinusoidal Endothelial Cells: Insights into Non-Alcoholic Fatty Liver Disease
    McMahan, Rachel H.
    Porsche, Cara E.
    Edwards, Michael G.
    Rosen, Hugo R.
    PLOS ONE, 2016, 11 (07):
  • [49] An extended fatty liver index to predict non-alcoholic fatty liver disease
    Kantartzis, K.
    Rettig, I.
    Staiger, H.
    Machann, J.
    Schick, F.
    Scheja, L.
    Gastaldelli, A.
    Bugianesi, E.
    Peter, A.
    Schulze, M. B.
    Fritsche, A.
    Haering, H. -U.
    Stefan, N.
    DIABETES & METABOLISM, 2017, 43 (03) : 229 - 239
  • [50] Comparison of fatty liver index with fibroscan in non-alcoholic fatty liver disease
    Ahmed, Marium
    Saeed, Rabeeya
    Kamani, Lubna
    Durrani, Noureen
    Ahmed, Faraz
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2024, 13 (04) : 1488 - 1495